Kyowa Hakko Bio
May 31, 2024
2023 Review
- Despite the difficulties in the amino acid business, revenue increased because of the steady sales growth of citicoline, mainly used in health foods, and more.
- Meanwhile, normalized operating profit decreased because of increases in fuel expenses and other variable costs, an intensifying competitive environment, the disappearance of special demand for materials for vaccine production, and other factors that have made for a continuously strict business environment for the amino acid business. The approval process of regulatory authorities for Human Milk Oligosaccharide (HMO) is in progress in numerous countries.
2024 Plan
- Reduce costs, mainly of the amino acid business, and focus on citicoline, a growing product, to reduce deficits. Concentrate on using citicoline, a highly profitable product, in health foods and continue to strive for the quick approval of HMO in numerous countries. Additionally, expand the use of each material.